PMID: 9194267Jun 15, 1997Paper

Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy

Statistics in Medicine
D L Fairclough

Abstract

Assessment of health related quality of life (QOL) has become an important endpoint in many clinical trials of cancer therapy. Most of these studies entail multiple QOL scales that are assessed repeatedly over time. As a result, the problem of multiple comparisons is a primary analytic challenge with these trials. The use of summary measures and statistics both reduces the number of hypotheses tested and facilitates the interpretation of trial results where the primary question is 'Does the overall QOL differ between treatment arms?' I present two classes of summary measures that are sensitive to consistent trends in the same direction across multiple assessment times or multiple QOL scales. Missing data strongly influences the choice between the two classes, where one class handles missing data on an individual basis, while the other class uses model-based strategies. I present the results from a clinical trial of adjuvant therapy for breast cancer that use summary measures with a focus on the practical issues that affect these analysis strategies, such as missing data and integration of QOL with efficacy endpoints such as survival.

Citations

Feb 25, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Eileen MannionDympna Waldron
May 26, 1999·Respirology : Official Journal of the Asian Pacific Society of Respirology·Y IshiharaS Kitamura
Apr 4, 2006·Hematology/oncology Clinics of North America·Farzan SiddiquiBenjamin Movsas
Nov 25, 2006·Current Problems in Cancer·Amylou Dueck, Paul J Novotny
Nov 7, 2006·Archives of Physical Medicine and Rehabilitation·Carolina Moriello, Nancy E Mayo
Aug 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F JolyI F Tannock
May 25, 2005·Cancer·Charles L LoprinziUNKNOWN North Central Cancer Treatment Group
Aug 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Yanni Hao
Jun 15, 2012·Health and Quality of Life Outcomes·Dennis A RevickiSrividya Kotapati
Feb 22, 2013·Statistical Methods in Medical Research·Melanie L Bell, Diane L Fairclough
Jul 17, 1999·Statistics in Medicine·R Z OmarS G Thompson
Apr 8, 2004·Statistical Methods in Medical Research·Diane L Fairclough
Jan 5, 2007·Oncology Nursing Forum·Claudette G Varricchio
Mar 11, 2009·Acta Oncologica·Nina HelbekkmoUNKNOWN Norwegian Lung Cancer Study Group
Mar 2, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Joshua R NiskaJeff A Sloan
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew P GoetzJoseph Rubin
Mar 19, 2004·Journal of Biopharmaceutical Statistics·Diane L FaircloughGeorge Papadopoulos
Jan 18, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·I BarofskyM Eberhardt
Dec 2, 2005·Statistics in Medicine·Beatrijs MoerkerkeVeronique Cocquyt
Oct 3, 2014·Journal of Comparative Effectiveness Research·Carolyn E Schwartz, Donald L Patrick
Dec 13, 2000·Statistics in Medicine·H J RibaudoT G Allen-Mersh
Apr 2, 2002·Statistical Methods in Medical Research·H J Ribaudo, S G Thompson
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teresa A RummansJean Hanson
Dec 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Farzan SiddiquiBenjamin Movsas
Jan 10, 2002·Statistics in Medicine·Chen WangSusan Anderson
Mar 23, 2019·Kidney International·Pietro A CanettaUNKNOWN CureGN Consortium
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D E EdiebahUNKNOWN Quality of Life Department and Patient Reported Outcome and Behavioural Evidence (PROBE)
Jul 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-J GrobA Hauschild
Feb 3, 2020·The Lancet Oncology·Corneel CoensUNKNOWN Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.